Antiarrhythmic Potential of Drugs Targeting the Cardiac Ryanodine Receptor Ca2+ Release Channel: Case Study of Dantrolene

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|8|1062-1072

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.8, 2015-01, pp. : 1062-1072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing New Anti-Arrhythmics: Clues from the Molecular Basis of Cardiac Ryanodine Receptor (RyR2) Ca2+-Release Channel Dysfunction

By  

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3195-3211

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclic ADP-ribose, the ryanodine receptor and Ca 2+ release

By Sitsapesan R.   McGarry S.J.   Williams A.J.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 11, 1995-11 ,pp. : 386-391

Elsevier

Access to resources Recommend Favorite

2-Hydroxycarbazole induces Ca 2+ release from sarcoplasmic reticulum by activating the ryanodine receptor

By Tovey S.C.   Longland C.L.   Mezna M.   Michelangeli F.  

European Journal of Pharmacology, Vol. 354, Iss. 2, 1998-08 ,pp. : 245-251

Elsevier

Access to resources Recommend Favorite

The Ryanodine Receptor: A Pivotal Ca2+ Regulatory Protein and Potential Therapeutic Drug Target

By  

Current Drug Targets, Vol. 12, Iss. 5, 2011-05 ,pp. : 709-723

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of dantrolene sodium on intracellular Ca 2+ -handling in normal and Ca 2+ -overloaded cardiac muscle

By Meissner A.   Szymanska G.   Morgan J.P.  

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 333-342

Elsevier

Access to resources Recommend Favorite